4.5 Article

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients

Ting-Shun Wang et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)

Article Immunology

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage

Oscar Medina-Contreras et al.

JOURNAL OF IMMUNOLOGY (2016)

Letter Dermatology

Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab

Alexander Boehner et al.

JAMA DERMATOLOGY (2016)

Article Biochemistry & Molecular Biology

Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor

Siddhartha S. Saha et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Letter Dermatology

A case of acute generalized pustular psoriasis of von Zumbusch treated with adalimumab

S. Gkalpakiotis et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Dermatology

IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient

Yael Renert-Yuval et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)

Letter Dermatology

Novel IL36RN gene mutation revealed by analysis of 8 Japanese patients with generalized pustular psoriasis

Mitsuha Hayashi et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2014)

Letter Dermatology

Loss of IL36RN Function Does Not Confer Susceptibility to Psoriasis Vulgaris

Dorottya M. Berki et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Letter Dermatology

1L36RN Mutations Underlie Impetigo Herpetiformis

Kazumitsu Sugiura et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Letter Dermatology

Mutation analysis of IL36RN in a Chinese Daur family with generalized pustular psoriasis

Dan Shu et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2014)

Article Rheumatology

The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium

Silke Frey et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

Editorial Material Immunology

IL-36 RECEPTOR ANTAGONIST WITH SPECIAL EMPHASIS ON IL-38

Y. Shaik et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2013)

Article Dermatology

Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis

Nobuo Kanazawa et al.

JOURNAL OF DERMATOLOGY (2013)

Editorial Material Dermatology

IL36RN Mutations in Generalized Pustular Psoriasis: Just the Tip of the Iceberg?

Francesca Capon

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Letter Dermatology

Rare Variations in IL36RN in Severe Adverse Drug Reactions Manifesting as Acute Generalized Exanthematous Pustulosis

Alexander A. Navarini et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Letter Dermatology

Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes

Niovi Setta-Kaffetzi et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Letter Dermatology

Mutations in IL36RN in Patients with Generalized Pustular Psoriasis

Andreas Koerber et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Editorial Material Dermatology

DIRA, DITRA, and New Insights Into Pathways of Skin Inflammation What's in a Name?

Edward W. Cowen et al.

ARCHIVES OF DERMATOLOGY (2012)

Article Pharmacology & Pharmacy

IL-36 in psoriasis

J. E. Towne et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Article Medicine, Research & Experimental

Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk

Luigi Tortola et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Biochemistry & Molecular Biology

Structure of the activating IL-1 receptor signaling complex

Christoph Thomas et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)

Article Genetics & Heredity

Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis

Alexandros Onoufriadis et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2011)

Article Biochemistry & Molecular Biology

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

Jennifer E. Towne et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Medicine, General & Internal

Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

Slaheddine Marrakchi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Immunology

IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis

Hal Blumberg et al.

JOURNAL OF IMMUNOLOGY (2010)

Review Immunology

Immunogenicity of protein therapeutics

Anne S. De Groot et al.

TRENDS IN IMMUNOLOGY (2007)

Article Immunology

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

Hal Blumberg et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Immunology

A new nomenclature for IL-1-family genes

JE Sims et al.

TRENDS IN IMMUNOLOGY (2001)